Webcast Alert for VisiJet, Inc.: Trilogy Capital's Emerging Growth Microcap Forum Announces the Addition of Two Keynote Speakers
21 Novembre 2003 - 4:18PM
PR Newswire (US)
Webcast Alert for VisiJet, Inc.: Trilogy Capital's Emerging Growth
Microcap Forum Announces the Addition of Two Keynote Speakers To
Today's Webcast at 12 p.m. ET Richard Giest, Ph.D, and Paul Cohen
to Speak IRVINE, Calif., Nov. 21 /PRNewswire/ -- VisiJet, Inc.
(BULLETIN BOARD: VJET.OB) will webcast the following presentation:
What: VisiJet (OTC:VJET.OB) (BULLETIN BOARD: VJET.OB) will give a
presentation at Informed Investors Emerging Growth/Microcap Stocks
Forum When: November 21, 2003 @ 12:00 PM Eastern Time Where:
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339
How: Live over the Internet -- Simply log on to the web at the
address above. Contact: AJ Cervantes, Trilogy Capital, ,
800-330-1860 If you are unable to participate during the live
webcast, the call will be available for replay at
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339.
The keynote speakers today include Dr. Richard Geist, a well-known
commentator, financial analyst and author of the recent national
publication, Investment Therapy, available in major bookstores, as
well as The Psychology of Investing, which was published in 2001.
Dr. Geist appears regularly as an analyst for such programs as CNBC
and CNN. In addition, Mr. Paul Cohen, the editor and publisher of
the Cohen Independent Research Report will also speak on Microcap
investing and the Microcap rationale. VisiJet, Inc., a medical
device company based in Irvine, California, is focused on the
development and marketing of innovative ophthalmic applications
that will result in faster, safer and more efficacious procedures
in two of the largest surgical markets in the world: refractive and
cataract surgeries. VisiJet's lead products, the HydroKeratome(R)
and Pulsatome(R), utilize the Company's proprietary and patented
waterjet technology. These devices uses a high-pressure micro beam
of water the diameter of a human hair to cut ocular tissue. The
FDA-approved HydroKeratome(R), uses the waterjet technology to cut
the cornea as required in LASIK surgery. The Pulsatome(R),
currently under development, is a device that uses waterjet
technology to remove cataracts -- the most performed surgical
procedure in the world. For more information visit
http://www.visijet.com/. About Trilogy Capital Trilogy's Emerging
Growth Microcap Forums, hosted by InformedInvestor.com, provide the
perfect online forum for publicizing the compelling stories of
potentially high-growth Microcap companies. Trilogy is committed to
identifying overlooked and undervalued emerging growth companies
that may be poised to revolutionize their fields, create great
products and deliver exceptional performance for their investors.
Trilogy Capital Partners, Inc. is a proactive financial services
company engaged in corporate communications, investor relations and
strategic planning. Based on the simple concept that many well-run
public companies are not realizing their full value in the
marketplace, Trilogy has aggregated highly experienced executives
into a formidable financial and marketing team. Our team utilizes
proactive, technology-driven strategies and tools to drive public
company visibility. For more information, please visit
http://www.trilogy-capital.com/ or contact Racquel Rivera at .
FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424,
DATASOURCE: VisiJet, Inc. CONTACT: AJ Cervantes of Trilogy Capital,
or +1-800-330-1860 or Janet Scharr of Informed Investors,
+1-804-327-3424, Web site: http://www.informedinvestors.com/
http://www.trilogy-capital.com/ http://www.visijet.com/
Copyright